Letter to the Editor: Prospective study of algorithm-based chemoradioselection to optimize treatment intensity for...

The new prospective study by Hongo et al. on algorithm-based chemoradioselection (CRS) for advanced head and neck cancer signifies a crucial advancement in optimizing treatment intensity while reconciling oncological outcomes with organ preservation. The authors utilized CRS to provide a viable approach for patient stratification and therapeutic personalization, thus minimizing overtreatment while maintaining sufficient tumor control. This novel method addresses the enduring issue of tailoring multimodal treatment for advanced cases, where both effectiveness and quality of life are crucial. The study emphasizes the clinical significance of evidence-based algorithms in enhancing therapeutic decision-making. Future investigations incorporating molecular biomarkers, artificial intelligence, and validation within extensive, multi-institutional cohorts will improve the precision and applicability of CRS, thereby strengthening its potential to establish itself as a standard tool in head and neck oncology.